Sandu Pharmaceuticals share news, announcements and annual reports
BSE: 524703Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹34.63.
28 Oct: open ₹32.81, high ₹37.80, low ₹32.60
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹36 Cr3,677th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.09
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.81
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.72%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 5.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,688
Sandu Pharmaceuticals has 659 announcements on record, routine notices left out; 2 in the 30 days to 28 Oct 2026, the latest on 9 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Sandu Pharmaceuticals quarterly results
The board met on 11 Aug 2026 to consider quarterly results
Notice filed 3 Aug 2026
Sandu Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.Sandu Pharmaceuticals financials, year by year
Annual reports30
- Annual report, year to Mar 202619 Aug 2026
- Annual report, year to Mar 20256 Sep 2025
- Annual report, year to Mar 20245 Sep 2024
- Annual report, year to Mar 20236 Sep 2023
- Annual report, year to Mar 20227 Sep 2022
25 earlier reports
- Annual report, year to Mar 20216 Sep 2021
- Annual report, year to Mar 20207 Sep 2020
- Annual report, year to Mar 20193 Sep 2019
- Annual report, year to Mar 20182 Oct 2018
- Annual report, year to Mar 20175 Oct 2017
- Annual report, year to Mar 20163 Oct 2016
- Annual report, year to Mar 20155 Sep 2015
- Annual report, year to Mar 201411 Sep 2014
- Annual report, year to Mar 201317 Sep 2013
- Annual report, year to Mar 2012Filing day not known
- Annual report, year to Mar 201112 Dec 2011
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 2003Filing day not known
- Annual report, year to Mar 2002Filing day not known
- Annual report, year to Mar 2001Filing day not known
- Annual report, year to Mar 2000Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
- Annual report, year to Mar 1997Filing day not known
Sandu Pharmaceuticals share news and announcements
Newest first. Page 1 of 14.
Oct 2026
9 Oct · Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta.
Sep 2026
12 Sep · Meeting
Aug 2026
19 Aug · Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Registered With The Company/RTA
19 Aug · Meeting
11 Aug · Approval Of Material Related Party Transactions Subject To Approval Of Shareholders
11 Aug · Meeting
11 Aug · Corporate action
11 Aug · Meeting
11 Aug · Results
11 Aug · Unaudited Financials For Q Ended 30.06.2026
11 Aug · Results
11 Aug · Results
3 Aug · Board meeting
Meeting on 11 Aug 2026: quarterly results
Jul 2026
11 Jul · Announcement Under Regulation 30-Reconstitution Of Committees Of Board-Audit/Nomination/Stakeholders
11 Jul · Board meeting
6 Jul · Board meeting
Meeting on 11 Jul 2026
Jun 2026
20 Jun · Announcement Under Regulation 30
19 Jun · Management
19 Jun · Announcement under Regulation 30 (LODR)-Demise
May 2026
5 May · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
5 May · Management
5 May · Dividend
5 May · Audited Financials For The Q And Year Ended 31.03.2026
5 May · Results
Apr 2026
27 Apr · Board meeting
Meeting on 5 May 2026: audited results and final dividend
Feb 2026
6 Feb · Business
6 Feb · Results
Jan 2026
27 Jan · Board meeting
Meeting on 6 Feb 2026: quarterly results
Dec 2025
Nov 2025
19 Nov · : Intimation Regarding Receipt Of Approval Of Shareholders For Reclassification Of M/S Akshath Finvest And Properties Private Limited Persons Forming Part Of The 'Promoter/Promoter Group' Category To The 'Public' Category.
12 Nov · Results
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 12 Aug 2026Board or managers changeddown 0.43%−0.4 pts vs Nifty 500market median 0.0% · five sessions −3.7% (−2.8 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 22 Jun 2026Board or managers changeddown 1.47%−2.0 pts vs Nifty 500market median 0.0% · five sessions −4.1% (−3.5 pts vs Nifty 500) · volume 1.3× usual · The announcement
- 6 May 2026Dividenddown 0.50%−1.9 pts vs Nifty 500market median 0.0% · five sessions −8.7% (−6.4 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 6 May 2026Board or managers changeddown 0.50%−1.9 pts vs Nifty 500market median 0.0% · five sessions −8.7% (−6.4 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 27 Apr 2026Dividendup 5.30%+4.2 pts vs Nifty 500market median 0.0% · five sessions −1.8% (−3.0 pts vs Nifty 500) · volume 3.9× usual · The announcement
- 1 Oct 2025Board or managers changeddown 1.03%−1.9 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−4.8 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 29 May 2025Dividenddown 4.14%−4.5 pts vs Nifty 500market median 0.0% · five sessions −7.4% (−7.6 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 29 May 2025Board or managers changeddown 4.14%−4.5 pts vs Nifty 500market median 0.0% · five sessions −7.4% (−7.6 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 19 May 2025Dividendup 2.83%+2.9 pts vs Nifty 500market median 0.0% · five sessions +2.4% (+2.8 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 14 Feb 2025Board or managers changedup 5.44%+6.7 pts vs Nifty 500market median 0.0% · five sessions +5.0% (+5.4 pts vs Nifty 500) · volume 2.0× usual · The announcement
19 earlier announcements
- 13 Aug 2024Dividenddown 1.82%−0.9 pts vs Nifty 500market median 0.0% · five sessions +3.4% (+1.8 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 5 Aug 2024Dividenddown 2.46%+0.6 pts vs Nifty 500market median 0.0% · five sessions −2.1% (−0.7 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 12 Apr 2024Board or managers changeddown 0.81%0.0 pts vs Nifty 500market median 0.0% · five sessions −6.9% (−4.4 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 1 Apr 2024Board or managers changedup 3.14%+2.0 pts vs Nifty 500market median 0.0% · five sessions +11.3% (+9.0 pts vs Nifty 500) · volume 1.2× usual · The announcement
- 23 Nov 2023Board or managers changeddown 2.20%−2.3 pts vs Nifty 500market median 0.0% · five sessions −6.5% (−8.6 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 22 Nov 2023Board or managers changedup 5.00%+5.0 pts vs Nifty 500market median 0.0% · five sessions +0.7% (−0.9 pts vs Nifty 500) · volume 2.0× usual · The announcement
- 14 Sep 2023Dividendup 7.03%+6.6 pts vs Nifty 500market median 0.0% · five sessions +7.0% (+8.3 pts vs Nifty 500) · volume 2.2× usual · The announcement
- 16 Aug 2023Dividendup 0.74%+0.6 pts vs Nifty 500market median 0.0% · five sessions +3.6% (+3.2 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 7 Aug 2023Dividendup 5.72%+5.3 pts vs Nifty 500market median 0.0% · five sessions +8.2% (+8.4 pts vs Nifty 500) · volume 3.7× usual · The announcement
- 30 Aug 2022Dividendup 1.72%−0.6 pts vs Nifty 500market median 0.0% · five sessions +2.2% (0.0 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 16 Aug 2022Dividendup 3.91%+3.0 pts vs Nifty 500market median 0.0% · five sessions +3.5% (+4.4 pts vs Nifty 500) · volume 1.9× usual · The announcement
- 1 Aug 2022Dividenddown 3.69%−4.9 pts vs Nifty 500market median 0.0% · five sessions −8.0% (−9.6 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 15 Nov 2021Board or managers changeddown 1.21%−1.3 pts vs Nifty 500market median 0.0% · five sessions −8.7% (−4.8 pts vs Nifty 500) · volume 2.1× usual · The announcement
- 16 Aug 2021Dividendup 3.88%+3.8 pts vs Nifty 500market median 0.0% · five sessions −2.7% (−1.8 pts vs Nifty 500) · volume 1.0× usual · The announcement
- 3 Aug 2021Dividenddown 0.74%−1.9 pts vs Nifty 500market median 0.0% · five sessions −1.2% (−2.3 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 16 Mar 2020Credit ratingdown 4.51%+2.5 pts vs Nifty 500market median 0.0% · five sessions −9.0% (+3.3 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 26 Mar 2019Board or managers changedup 5.90%+4.8 pts vs Nifty 500market median 0.0% · five sessions +12.6% (+9.5 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 5 Mar 2018Credit ratingdown 0.26%+0.7 pts vs Nifty 500market median 0.0% · five sessions −11.0% (−8.4 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 3 Jun 2014Board or managers changeddown 4.96%−5.7 pts vs Nifty 500market median 0.0% · five sessions −1.8% (−6.6 pts vs Nifty 500) · volume 0.9× usual